Cooley Advises Quell Therapeutics on its Exclusive Treg Collaboration With AstraZeneca

June 9, 2023

Cooley advised Quell Therapeutics, a leading T-regulatory (Treg) cell therapy biotech company based in London, on its exclusive collaboration with AstraZeneca.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Frances Stocks Allen
Partner, London
Tom Goodman
Partner, London
Jiqiang Lin
Associate, New York
J. Brian Stalter
Special Counsel, New York
Ellen Dewhurst
Associate, London

Related Practices & Industries